Kevin Carrasco
Nancy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The potential of targeting TREM-1 in IBD.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: November 09, 2024
sTREM-1 is a specific biomarker of TREM-1 pathway activation.
Journal: Cellular & molecular immunology
Published: April 30, 2021
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis.
Journal: Cellular & molecular immunology
Published: May 25, 2020
Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation.
Journal: Frontiers in immunology
Published: June 25, 2019
Inhibition of triggering receptor expressed on myeloid cells-1 impairs thrombin generation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 27, 2019
Effects of Porphyromonas gingivalis LPS and LR12 peptide on TREM-1 expression by monocytes.
Journal: Journal of clinical periodontology
Published: December 14, 2017
Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock.
Journal: Cardiovascular research
Published: August 02, 2017
TREM-1 multimerization is essential for its activation on monocytes and neutrophils.
Journal: Cellular & molecular immunology
Published: July 31, 2017
Triggering Receptor Expressed on Myeloid cells-1: a new player in platelet aggregation.
Journal: Thrombosis and haemostasis
Published: March 07, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026